Literature DB >> 19445914

Concurrent decline of several antioxidants and markers of oxidative stress during combination chemotherapy for small cell lung cancer.

Marika Crohns1, Kari Liippo, Marina Erhola, Hannu Kankaanranta, Eeva Moilanen, Hannu Alho, Pirkko Kellokumpu-Lehtinen.   

Abstract

OBJECTIVES: To investigate the oxidant effects of adriamycin-containing chemotherapy (CT), we evaluated various antioxidants, total antioxidant capacity (TRAP) and different parameters of oxidative and nitrosative stress during combination CT. DESIGN AND METHODS: Blood samples were obtained from 16 small cell lung cancer patients at baseline and several times during the first, second and sixth CT cycles.
RESULTS: There were significant decreases in serum urate and serum proteins during all cycles, serum TRAP during the first two cycles, plasma ascorbic acid and serum TBARS during the first cycle, and serum conjugated dienes and plasma alphatocopherol during the last cycle. The baseline levels of tocopherols increased significantly between the first and sixth CT cycles. Higher levels of baseline plasma thiols were associated with better overall survival (p=0.008).
CONCLUSIONS: Adriamycin-containing CT causes significant oxidative stress as implied by reduced levels of protective antioxidants. Long-term CT treatment seems to enhance lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19445914     DOI: 10.1016/j.clinbiochem.2009.05.003

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

Review 1.  Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress.

Authors:  Laura A A Gilliam; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2011-06-15       Impact factor: 8.401

2.  Radiotherapy Is Associated with an Accelerated Risk of Carotid Atherosclerosis in Patients with Nasopharyngeal Carcinoma: A Nine-Year Prospective Follow-Up Study.

Authors:  Cheng-Hsien Lu; Yun-Ru Lai; Fu-Min Fang; Teng-Yeow Tan; Wen-Chan Chiu; Dong-Yi Hsieh; Chih-Cheng Huang; Chia-Yi Lien; Ben-Chung Cheng; Chih-Yen Chien; Tai-Lin Huang; Chia-Te Kung
Journal:  Cancers (Basel)       Date:  2022-02-27       Impact factor: 6.639

3.  The Cardiac Markers and Oxidative Stress Parameters in Advanced Non-Small Cell Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy.

Authors:  Urszula Demkow; Beata Biatas-Chromiec; Anna Stelmaszczyk-Emmel; Elzbieta Radzikowska; Elzbieta Wiatr; Piotr Radwan-Rohrenschef; Monika Szturmowicz
Journal:  EJIFCC       Date:  2011-03-14

4.  Role of diagnostic factors associated with antioxidative status and expression of matrix metalloproteinases (MMPs) in patients with cancer therapy induced ocular disorders.

Authors:  Mahmood Rasool; Arif Malik; Muhammad Abdul Basit Ashraf; Mahwish Arooj; Asia Kiran; Sulayman Waquar; Ujala Ayyaz; Ayesha Zahid; Ahmad Zaheer; Abdul Jabbar; Maryam Zain; Amir Raza; Asim Mehmood; Tahira Batool Qaisrani; Zeenat Mirza; Mohammed Hussein Al-Qahtani; Sajjad Karim; Absarul Haque
Journal:  Saudi J Biol Sci       Date:  2018-08-12       Impact factor: 4.219

5.  Antioxidant effect of acetyl-l-carnitine against cisplatin-induced cardiotoxicity.

Authors:  Serdar Bayrak; Safiye Aktaş; Zekiye Altun; Yasemin Çakir; Merve Tütüncü; Selen Kum Özşengezer; Osman Yilmaz; Nur Olgun
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.